Cognos Therapeutics Inc

CIK 1651490 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Cognos Therapeutics Inc.

Recent SEC filings

FiledFormAccession number
Jul 2, 2026D0001651490-26-000003
Mar 31, 2022D0001651490-22-000001
Oct 12, 2021D0001651490-21-000004
Jul 16, 2021D0001651490-21-000002
May 21, 2021D/A0001651490-21-000001
Dec 29, 2020D0001651490-20-000002
May 29, 2018D0001651490-18-000002
Feb 15, 2018D0001651490-18-000001
Apr 20, 2016D0001651490-16-000003
Dec 10, 2015D/A0001651490-15-000002
Aug 24, 2015D0001651490-15-000001